AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23220316 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2: photocured after a delay of 2 minutes
Number of subjects: 60
Study 23220316 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3: encapsulated material pre-warmed at 40° C for 90 seconds
Number of subjects: 60
Study 23220316 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 4: capsules pre-warmed and photocuring delayed for 2.4 minutes
Number of subjects: 60
Study 21389794 — intervention group
Group type: EXPERIMENTAL
Intervention: Introduction of small quantities of gluten to infants while breast-feeding
Number of subjects: 0
Study 21389794 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 0
Study 21389794 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish population-based CD screening study
Number of subjects: 0
Study 18484971 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe 40 mg/day
Number of subjects: 27
Study 18484971 — intervention group
Group type: COMPARATOR
Intervention: Ezetimibe 10 mg/day
Number of subjects: 27
Study 16648324 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole 15 mg/day
Number of subjects: 52
Study 16648324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 12859261 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol maleate/dorzolamide fixed combination (TDFC)
Number of subjects: 36
Study 12859261 — intervention group
Group type: COMPARATOR
Intervention: Timolol maleate/pilocarpine fixed combination (TPFC)
Number of subjects: 36
Study 10795432 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-lowering treatment
Number of subjects: 583
Study 10795432 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 583
Study 8971300 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once daily, amoxycillin 1000 mg b.d., clarithromycin 250 mg b.d. for 7 days (LAC group)
Number of subjects: 70
Study 8971300 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 30 mg once daily, amoxycillin 1000 mg b.d. for 7 days, plus azithromycin 500 mg once daily for 3 days (LAA group)
Number of subjects: 70
Study 8971300 — intervention group
Group type: EXPERIMENTAL
Intervention: LAC group
Number of subjects: 70
Study 8971300 — intervention group
Group type: COMPARATOR
Intervention: LAA group
Number of subjects: 70
Study 1628727 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled bradykinin
Number of subjects: 8
Study 1628727 — intervention group
Group type: COMPARATOR
Intervention: Inhaled histamine
Number of subjects: 8
Study 6441544 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (mean dose: 69.4 mg per day, given three times a day)
Number of subjects: 32
Study 6441544 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 31612844 — intervention group
Group type: EXPERIMENTAL
Intervention: State Entropy (SE) between 40 and 50
Number of subjects: 90
Study 31612844 — intervention group
Group type: COMPARATOR
Intervention: Fresh Gas Flow for 10 minutes (group T)
Number of subjects: 90
Study 31612844 — intervention group
Group type: COMPARATOR
Intervention: 0.8 Ratio of End-Expired Agent Concentration to Inspired Agent Concentration (group R)
Number of subjects: 90
Study 29103661 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary disease management program (MDMP) with discharge education, physical training, follow-up visits and telephone calls for 180 days
Number of subjects: 62
Study 29103661 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 62
Study 29103661 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary disease management program (MDMP)
Number of subjects: 62
Study 27577516 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-bolus spectral MDCT with virtual unenhanced imaging (1.5 mL/kg body weight, 4 mL/s flow rate)
Number of subjects: 90
Study 27577516 — intervention group
Group type: COMPARATOR
Intervention: Conventional tri-phasic enhanced CT (1.5 mL/kg body weight, 4 mL/s flow rate)
Number of subjects: 90
Study 27577516 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-bolus spectral MDCT
Number of subjects: 90
Study 27577516 — intervention group
Group type: COMPARATOR
Intervention: Conventional tri-phasic enhanced CT
Number of subjects: 90
Study 24668572 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 10
Study 24668572 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Interval Training (MIIT)
Number of subjects: 10
Study 22801348 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 470
Study 22801348 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 470
Study 22801348 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 470
Study 22801348 — intervention group
Group type: COMPARATOR
Intervention: Initial (day 0) RPR titer
Number of subjects: 470
Study 20228281 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice set size of 2, 5, 10, and 16 plans
Number of subjects: 0
Study 17426069 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil at 0.3 microg kg‐1 min‐1
Number of subjects: 40
Study 17426069 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil at 0.4 microg kg‐1 min‐1
Number of subjects: 40
Study 17426069 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol target-controlled infusion
Number of subjects: 40
Study 17426069 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine bolus
Number of subjects: 40
Study 15746195 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled ovarian hyperstimulation (COH)
Number of subjects: 1240
Study 12521450 — intervention group
Group type: EXPERIMENTAL
Intervention: Forceps
Number of subjects: 442
Study 12521450 — intervention group
Group type: COMPARATOR
Intervention: Vacuum
Number of subjects: 442
Study 9452153 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate Response Optimization (OPT)
Number of subjects: 37
Study 9452153 — intervention group
Group type: COMPARATOR
Intervention: Fixed Activity Rate Response Programming (FIXED)
Number of subjects: 37
Study 9097797 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative suture adjustment
Number of subjects: 25
Study 9097797 — intervention group
Group type: COMPARATOR
Intervention: Postoperative suture adjustment
Number of subjects: 25
Study 2576200 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepindolol (20 mg/9.8 cm2 patch)
Number of subjects: 9
Study 2576200 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg/9.8 cm2 patch)
Number of subjects: 9
Study 2576200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 23483 — intervention group
Group type: EXPERIMENTAL
Intervention: oral allopurinol
Number of subjects: 16
Study 23483 — intervention group
Group type: COMPARATOR
Intervention: sublingual procaine adenylate
Number of subjects: 16
Study 30843038 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 212
Study 30843038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study 28808905 — intervention group
Group type: COMPARATOR
Intervention: 801-mg tablet (fasted state)
Number of subjects: 44
Study 28808905 — intervention group
Group type: COMPARATOR
Intervention: 801-mg tablet (fed state)
Number of subjects: 44
Study 28808905 — intervention group
Group type: COMPARATOR
Intervention: Capsules (fasted state)
Number of subjects: 44
Study 28808905 — intervention group
Group type: COMPARATOR
Intervention: Capsules (fed state)
Number of subjects: 44
Study 26336692 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) follow-up system, 5 automated calls over 12 months
Number of subjects: 1608
Study 26336692 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) follow-up system
Number of subjects: 1608
Study 26336692 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1608
Study 23579036 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozonated oil
Number of subjects: 30
Study 23579036 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid gel
Number of subjects: 30
Study 21195293 — intervention group
Group type: EXPERIMENTAL
Intervention: Saam acupuncture
Number of subjects: 6
Study 21195293 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 6
Study 19372193 — intervention group
Group type: EXPERIMENTAL
Intervention: FOBT screening
Number of subjects: 10054
Study 16330517 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative radiotherapy (n = 208)
Number of subjects: 400
Study 16330517 — intervention group
Group type: COMPARATOR
Intervention: No post-operative radiotherapy (n = 192)
Number of subjects: 400
Study 16330517 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative radiotherapy
Number of subjects: 400
Study 16330517 — intervention group
Group type: EXPERIMENTAL
Intervention: Local recurrence
Number of subjects: 400
Study 16330517 — intervention group
Group type: COMPARATOR
Intervention: No local recurrence
Number of subjects: 400
Study 16330517 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment follow-up and investigation
Number of subjects: 400
Study 15320998 — intervention group
Group type: EXPERIMENTAL
Intervention: Game Group (new technologies + motivational game)
Number of subjects: 40
Study 15320998 — intervention group
Group type: COMPARATOR
Intervention: Control Group (new technologies alone)
Number of subjects: 40
Study 11252695 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (4 capsules/day, each containing 250 mg of L‐ascorbic acid, 100 IU of dl‐a‐tocopherol acetate, and 150 mg of alpha‐lipoic acid)
Number of subjects: 18
Study 11252695 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 18
Study 9276791 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidophilus milk containing strains B, N1, and E
Number of subjects: 11
Study 9276791 — intervention group
Group type: EXPERIMENTAL
Intervention: Acidophilus milk containing strain N1
Number of subjects: 11
Study 9276791 — intervention group
Group type: COMPARATOR
Intervention: Acidophilus milk containing strain ATCC 4356
Number of subjects: 11
Study 9276791 — intervention group
Group type: COMPARATOR
Intervention: Control reduced-fat (2% fat) milk
Number of subjects: 11
Study 8272392 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple out‐patient treatment
Number of subjects: 0
Study 8272392 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive physical training
Number of subjects: 0
Study 3323420 — intervention group
Group type: EXPERIMENTAL
Intervention: deprenyl
Number of subjects: 16
Study 3323420 — intervention group
Group type: COMPARATOR
Intervention: Madopar alone
Number of subjects: 16
Study 3323420 — intervention group
Group type: COMPARATOR
Intervention: Madopar with anti-cholinergics
Number of subjects: 16
Study 30499426 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily broccoli consumption (200 g cooked broccoli and 20 g raw daikon radish for 15 days, 100 g broccoli and 10 g daikon radish on day 16)
Number of subjects: 18
Study 30499426 — intervention group
Group type: COMPARATOR
Intervention: Control diet with no broccoli (NB) for 16 days
Number of subjects: 18
Study 27600862 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 918
Study 27600862 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 918
Study 27600862 — intervention group
Group type: COMPARATOR
Intervention: Canagliflozin (100 mg and 300 mg)
Number of subjects: 918
Study 27600862 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 918
Study 23316683 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate-based mouthrinse
Number of subjects: 16
Study 23316683 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetilpiridinium-based mouthrinse
Number of subjects: 16
Study 23316683 — intervention group
Group type: COMPARATOR
Intervention: Sterile tap water (control group)
Number of subjects: 16
Study 22987467 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-education programme
Number of subjects: 200
Study 22987467 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard instructions)
Number of subjects: 200
Study 19995617 — intervention group
Group type: EXPERIMENTAL
Intervention: Show Your Work (SYW) system turned 'on'
Number of subjects: 50
Study 19995617 — intervention group
Group type: COMPARATOR
Intervention: Show Your Work (SYW) system turned 'off'
Number of subjects: 50
Study 19995617 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey of pharmacies regarding SYW
Number of subjects: 50
Study 18760124 — intervention group
Group type: COMPARATOR
Intervention: DDD (control group, all OFF)
Number of subjects: 1300
Study 18760124 — intervention group
Group type: EXPERIMENTAL
Intervention: DDDRP (MVP + PAP + ATP ON)
Number of subjects: 1300
Study 18760124 — intervention group
Group type: EXPERIMENTAL
Intervention: MVP group (only MVP ON)
Number of subjects: 1300
Study 16364933 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD) oral gel
Number of subjects: 203
Study 16364933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study 12718756 — intervention group
Group type: EXPERIMENTAL
Intervention: Strain rate propagation velocity in patients with treated hypertension
Number of subjects: 25
Study 12718756 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow propagation velocity in patients with treated hypertension
Number of subjects: 25
Study 12718756 — intervention group
Group type: COMPARATOR
Intervention: Strain rate propagation velocity
Number of subjects: 25
Study 12718756 — intervention group
Group type: COMPARATOR
Intervention: Flow propagation velocity
Number of subjects: 25
Study 12718756 — intervention group
Group type: COMPARATOR
Intervention: Ratio between peak mitral flow velocity / strain rate propagation velocity
Number of subjects: 25
Study 10809913 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslexic subjects
Number of subjects: 30
Study 10809913 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 30
Study 8813907 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide (IND) 2.5 mg daily
Number of subjects: 12
Study 8813907 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCT) 50 mg daily
Number of subjects: 12
Study 8813907 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCT) 12.5 mg and 25 mg daily
Number of subjects: 12
Study 14621725 — intervention group
Group type: EXPERIMENTAL
Intervention: ganciclovir, 5 mg/kg twice daily (n = 12)
Number of subjects: 23
Study 14621725 — intervention group
Group type: COMPARATOR
Intervention: no treatment (n = 11)
Number of subjects: 23
Study 4019541 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin (25 mg/kg IV)
Number of subjects: 30
Study 4019541 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole (25 mg/kg IV)
Number of subjects: 30
Study 4019541 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin (25 mg/kg IV)
Number of subjects: 30
Study 29513036 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy (MT)
Number of subjects: 56
Study 29513036 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 56
Study 29513036 — intervention group
Group type: COMPARATOR
Intervention: Supine rest (Control)
Number of subjects: 56
Study 29933528 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with CZBG (4 g, twice daily)
Number of subjects: 235
Study 29933528 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy plus placebo
Number of subjects: 235
Study 25180798 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate 20 mg
Number of subjects: 100
Study 25180798 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate 50 mg
Number of subjects: 100
Study 25180798 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate 70 mg
Number of subjects: 100
Study 25180798 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil 250 mg
Number of subjects: 100
Study 22562731 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging Stroller with 11.36 kg (JS1)
Number of subjects: 27
Study 22562731 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging Stroller with 22.72 kg (JS2)
Number of subjects: 27
Study 22562731 — intervention group
Group type: COMPARATOR
Intervention: No Jogging Stroller (NoJS)
Number of subjects: 27
Study 22562731 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced trials with Jogging Stroller (JS1 and JS2)
Number of subjects: 27
Study 22562731 — intervention group
Group type: COMPARATOR
Intervention: Self-paced trials without Jogging Stroller (NoJS)
Number of subjects: 27
Study 20021709 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinstated context with rosemary
Number of subjects: 0
Study 20021709 — intervention group
Group type: COMPARATOR
Intervention: Switched context with lemon
Number of subjects: 0
Study 20021709 — intervention group
Group type: EXPERIMENTAL
Intervention: Odour-based mood induction with rosemary
Number of subjects: 0
Study 20021709 — intervention group
Group type: EXPERIMENTAL
Intervention: Odour distinctiveness with rosemary
Number of subjects: 0
Study 20021709 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 0
Study 18564805 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 90
Study 18564805 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 90
Study 18564805 — intervention group
Group type: EXPERIMENTAL
Intervention: Perilaryngeal Airway (CobraPLA, PLA)
Number of subjects: 90
Study 18564805 — intervention group
Group type: COMPARATOR
Intervention: All groups (LMA, LT, PLA)
Number of subjects: 90
Study 16162042 — intervention group
Group type: EXPERIMENTAL
Intervention: Pool Cool sun safety program
Number of subjects: 375
Study 16162042 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 375
Study 12386036 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pristinamycin
Number of subjects: 289
Study 12386036 — intervention group
Group type: COMPARATOR
Intervention: Intravenous then oral penicillin
Number of subjects: 289
Study 10188706 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant-focus cognitive instruction
Number of subjects: 54
Study 10188706 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-focus cognitive instruction
Number of subjects: 54
Study 10188706 — intervention group
Group type: COMPARATOR
Intervention: Mother-infant interaction
Number of subjects: 54
Study 10188706 — intervention group
Group type: COMPARATOR
Intervention: Mother-boyfriend interaction
Number of subjects: 54
Study 7589027 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg) in sauna sessions
Number of subjects: 8
Study 7589027 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (12.5 mg) in sauna sessions
Number of subjects: 8
Study 7589027 — intervention group
Group type: COMPARATOR
Intervention: Placebo in sauna sessions
Number of subjects: 8
Study 7589027 — intervention group
Group type: COMPARATOR
Intervention: Placebo in control sessions
Number of subjects: 8
Study 7589027 — intervention group
Group type: COMPARATOR
Intervention: Captopril (12.5 mg) in control sessions
Number of subjects: 8
Study 7589027 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (40 mg) in control sessions
Number of subjects: 8
Study 2124433 — intervention group
Group type: EXPERIMENTAL
Intervention: surgery + MMC + 5‐FU (chemotherapy)
Number of subjects: 819
Study 2124433 — intervention group
Group type: EXPERIMENTAL
Intervention: surgery + MMC + 5‐FU + OK‐432 or PSK (immunochemotherapy)
Number of subjects: 819
Study 2124433 — intervention group
Group type: COMPARATOR
Intervention: surgery alone (control group)
Number of subjects: 819
Study 7314008 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg aminophylline
Number of subjects: 10
Study 7314008 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/kg aminophylline
Number of subjects: 10
Study 7314008 — intervention group
Group type: EXPERIMENTAL
Intervention: High theophylline concentrations
Number of subjects: 10
Study 30846366 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenously administered oxytocin (single dose)
Number of subjects: 38
Study 30846366 — intervention group
Group type: EXPERIMENTAL
Intervention: Endogenous oxytocin levels
Number of subjects: 38
Study 29167034 — intervention group
Group type: EXPERIMENTAL
Intervention: BEWARE body awareness training
Number of subjects: 40
Study 29167034 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 40
Study 26552906 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound muscle thickness (MT) measurements
Number of subjects: 102
Study 26552906 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression-based prediction equations for estimating DXA-derived aLM
Number of subjects: 102
Study 23381803 — intervention group
Group type: EXPERIMENTAL
Intervention: ALKS-33
Number of subjects: 62
Study 23381803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 21547860 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates-based mat exercises (n = 38)
Number of subjects: 62
Study 21547860 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 24)
Number of subjects: 62
Study 19735037 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastery goal condition
Number of subjects: 102
Study 19735037 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-approach goal condition
Number of subjects: 102
Study 19735037 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-avoidance goal condition
Number of subjects: 102
Study 19735037 — intervention group
Group type: COMPARATOR
Intervention: All three goal conditions
Number of subjects: 102
Study 17893574 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral gabapentin 800 mg
Number of subjects: 20
Study 17893574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 15031278 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer education program
Number of subjects: 1004
Study 15031278 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1004
Study 11474662 — intervention group
Group type: EXPERIMENTAL
Intervention: Alefacept 0.025 mg/kg
Number of subjects: 229
Study 11474662 — intervention group
Group type: EXPERIMENTAL
Intervention: Alefacept 0.075 mg/kg
Number of subjects: 229